These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7724494)

  • 1. Aerosol deposition as a function of airway disease: cystic fibrosis.
    Martonen T; Katz I; Cress W
    Pharm Res; 1995 Jan; 12(1):96-102. PubMed ID: 7724494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computationally efficient analysis of particle transport and deposition in a human whole-lung-airway model. Part II: Dry powder inhaler application.
    Kolanjiyil AV; Kleinstreuer C; Sadikot RT
    Comput Biol Med; 2017 May; 84():247-253. PubMed ID: 27836120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deposition of coarse particles in cystic fibrosis: model predictions versus experimental results.
    Brown JS; Bennett WD
    J Aerosol Med; 2004; 17(3):239-48. PubMed ID: 15625816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung Deposition of Alpha1-Proteinase Inhibitor (Human) (A1-PI[H]) Inhalation Solution Using Two Inhalation Modes of the I-neb Adaptive Aerosol Delivery (AAD) System in Healthy Subjects and Subjects with Cystic Fibrosis.
    Häussermann S; Winnips C; Edelman J; Kappeler D; Herpich C; Ehlich H; Zanker D; Kietzig C; Sommerer K
    J Aerosol Med Pulm Drug Deliv; 2016 Jun; 29(3):242-50. PubMed ID: 26669827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mathematical model for the selective deposition of inhaled pharmaceuticals.
    Martonen TB
    J Pharm Sci; 1993 Dec; 82(12):1191-9. PubMed ID: 8308694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling breath-enhanced jet nebulizers to estimate pulmonary drug deposition.
    Wee WB; Leung K; Coates AL
    J Aerosol Med Pulm Drug Deliv; 2013 Dec; 26(6):387-96. PubMed ID: 23509934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating in vivo airway surface liquid concentration in trials of inhaled antibiotics.
    Hasan MA; Lange CF
    J Aerosol Med; 2007; 20(3):282-93. PubMed ID: 17894535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deposition patterns of aerosolized drugs within human lungs: effects of ventilatory parameters.
    Martonen TB; Katz IM
    Pharm Res; 1993 Jun; 10(6):871-8. PubMed ID: 8321856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled, Parametric, Individualized, 2-D and 3-D Imaging Measurements of Aerosol Deposition in the Respiratory Tract of Asthmatic Human Subjects for Model Validation.
    Fleming J; Conway J; Majoral C; Katz I; Caillibotte G; Pichelin M; Montesantos S; Bennett M
    J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):432-51. PubMed ID: 25859710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional deposition of coarse particles and ventilation distribution in healthy subjects and patients with cystic fibrosis.
    Brown JS; Zeman KL; Bennett WD
    J Aerosol Med; 2001; 14(4):443-54. PubMed ID: 11791685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational Models of Inhalation Therapy in Early Childhood: Therapeutic Aerosols in the Developing Acinus.
    Katan JT; Hofemeier P; Sznitman J
    J Aerosol Med Pulm Drug Deliv; 2016 Jun; 29(3):288-98. PubMed ID: 26907858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mice-to-men comparison of inhaled drug-aerosol deposition and clearance.
    Kolanjiyil AV; Kleinstreuer C; Kleinstreuer NC; Pham W; Sadikot RT
    Respir Physiol Neurobiol; 2019 Feb; 260():82-94. PubMed ID: 30445230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient-specific modeling of regional antibiotic concentration levels in airways of patients with cystic fibrosis: are we dosing high enough?
    Bos AC; van Holsbeke C; de Backer JW; van Westreenen M; Janssens HM; Vos WG; Tiddens HA
    PLoS One; 2015; 10(3):e0118454. PubMed ID: 25734630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of age on aerosol deposition in children with cystic fibrosis.
    Chua HL; Collis GG; Newbury AM; Chan K; Bower GD; Sly PD; Le Souef PN
    Eur Respir J; 1994 Dec; 7(12):2185-91. PubMed ID: 7713202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of theoretical and experimental particle diffusion data within human airway casts.
    Zhang Z; Martonen T
    Cell Biochem Biophys; 1995-1996; 27(2):97-108. PubMed ID: 9106394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting aerosol deposition in patients with cystic fibrosis: effects of alterations in particle size and inspiratory flow rate.
    Laube BL; Jashnani R; Dalby RN; Zeitlin PL
    Chest; 2000 Oct; 118(4):1069-76. PubMed ID: 11035679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive expiratory pressure changes aerosol distribution in patients with cystic fibrosis.
    Laube BL; Geller DE; Lin TC; Dalby RN; Diener-West M; Zeitlin PL
    Respir Care; 2005 Nov; 50(11):1438-44. PubMed ID: 16253150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of functional respiratory imaging to characterize the effect of inhalation profile and particle size on lung deposition of inhaled corticosteroid/long-acting β2-agonists delivered via a pressurized metered-dose inhaler.
    Van Holsbeke C; De Backer J; Vos W; Marshall J
    Ther Adv Respir Dis; 2018; 12():1753466618760948. PubMed ID: 29499614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surfactant Driven Post-Deposition Spreading of Aerosols on Complex Aqueous Subphases. 1: High Deposition Flux Representative of Aerosol Delivery to Large Airways.
    Khanal A; Sharma R; Corcoran TE; Garoff S; Przybycien TM; Tilton RD
    J Aerosol Med Pulm Drug Deliv; 2015 Oct; 28(5):382-93. PubMed ID: 25723759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Model of mucociliary clearance in cystic fibrosis lungs.
    Kurbatova P; Bessonov N; Volpert V; Tiddens HA; Cornu C; Nony P; Caudri D;
    J Theor Biol; 2015 May; 372():81-8. PubMed ID: 25746843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.